Specialty drugs, biologics have side effects for employers – soaring costs

Employers face tough decisions around rising health costs

Employers are facing some tough realities and tough decisions when it comes to health benefit plans because of a rising tide of very expensive, non-traditional drug therapies.

To read the full story, login below.

Not a subscriber?

Start your subscription today!